| Target Price | $256.15 |
| Price | $200.87 |
| Potential |
27.52%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target Revolution Medicines Inc 2027 .
The average Revolution Medicines Inc target price is $256.15.
This is
27.52%
register free of charge
$336.00
67.27%
register free of charge
$180.79
10.00%
register free of charge
|
|
| A rating was issued by 28 analysts: 26 Analysts recommend Revolution Medicines Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Revolution Medicines Inc stock has an average upside potential 2027 of
27.52%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Brookline Capital |
Locked
➜
Locked
|
Locked | Sep 28 2026 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Sep 24 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Sep 10 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 31 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Aug 28 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Brookline Capital:
Locked
➜
Locked
|
Sep 28 2026 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Sep 24 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Sep 10 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 31 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Aug 28 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


